Immune activation of vaginal human Langerhans cells increases susceptibility to HIV-1 infection

Sci Rep. 2023 Feb 25;13(1):3283. doi: 10.1038/s41598-023-30097-x.

Abstract

Vaginal inflammation increases the risk for sexual HIV-1 transmission but underlying mechanisms remain unclear. In this study we assessed the impact of immune activation on HIV-1 susceptibility of primary human vaginal Langerhans cells (LCs). Vaginal LCs isolated from human vaginal tissue expressed a broad range of TLRs and became activated after exposure to both viral and bacterial TLR ligands. HIV-1 replication was restricted in immature vaginal LCs as only low levels of infection could be detected. Notably, activation of immature vaginal LCs by bacterial TLR ligands increased HIV-1 infection, whereas viral TLR ligands were unable to induce HIV-1 replication in vaginal LCs. Furthermore, mature vaginal LCs transmitted HIV-1 to CD4 T cells. This study emphasizes the role for vaginal LCs in protection against mucosal HIV-1 infection, which is abrogated upon activation. Moreover, our data suggest that bacterial STIs can increase the risk of HIV-1 acquisition in women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • HIV Infections*
  • HIV Seropositivity*
  • HIV-1* / physiology
  • Humans
  • Langerhans Cells
  • Ligands
  • Sexually Transmitted Diseases*

Substances

  • Ligands